LISA SORREL: Open Payments
NPI 1053618413 · CLINTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$246 in 11 payments from 7 companies in 2025. Trend: 2023 $609 · 2024 $425 · 2025 $246
Food & beverage: $246
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| Alpha Cognition USA, Inc. | 1 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $37 |
| Lundbeck LLC | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: REXULTI, Zunveyl, Kerendia, AUSTEDO XR, INGREZZA, TRINTELLIX.
Industry payments across LA — which companies pay providers there.
